US Archives - Page 3 of 117 - European Medical Journal

Rising Screen Time a Pressing Public Health Concern

Excessive screen time among children and adolescents has become a pressing public health concern, with mounting evidence linking digital media overuse to adverse physical, mental, and developmental outcomes.

Ibuprofen Emerges as Protective Factor Against Endometrial Cancer

Frequent ibuprofen use was associated with a reduced risk of endometrial cancer, while aspirin showed no measurable effect, according to a large cohort analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

How Do Breakfast Habits Influence Clinical Depression Risk?

Skipping breakfast is significantly associated with a higher risk of depression, according to a new systematic review and meta-analysis.

Emotional Distress Weakens Immunotherapy Response in Lung Cancer

Emotional distress before treatment is strongly associated with poorer responses to immunotherapy in patients with advanced non-small cell lung cancer (NSCLC), according to new research.

Climate Changes Alter Flu Patterns After Pandemic

Pandemic-era disruptions have permanently altered the climate-influenza relationship, with new subtype-specific thresholds emerging in Southern China, according to a large-scale analysis spanning 2011 to 2024.

Can Power Doppler Forecast Remission in Rheumatoid Arthritis?

Power Doppler ultrasound may provide important signals in predicting treatment response for patients with rheumatoid arthritis (RA), though its ability to forecast remission remains uncertain, according to a new systematic review.

New Review Finds Oral Probiotics Improve Acne Outcomes

Oral probiotics may offer therapeutic benefits for patients with acne, according to a new systematic review and meta-analysis of randomized trials.

Nanomedicine Breakthrough Improves Drug Delivery in Pediatric Brain Tumors

Pediatric central nervous system (CNS) tumors remain among the most fatal childhood cancers, largely because the blood-brain barrier (BBB) restricts effective therapeutic delivery and worsens clinical outcomes.

Targeted Therapies Offer Hope in Inflammatory Myopathies

Idiopathic inflammatory myopathies are complex immune-mediated disorders with multisystem involvement, and recent advances are reshaping both classification and treatment approaches.

Elexacaftor-Tezacaftor-Ivacaftor Cuts Liver Complications in Cystic Fibrosis

The availability of elexacaftor–tezacaftor–ivacaftor (ETI) has been associated with a marked reduction in cystic fibrosis liver disease (CFLD) progression, according to a nationwide analysis.